• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Marked discordance between cytogenetic/molecular and morphologic findings in a patient with chronic myeloid leukemia.

作者信息

Rashidi Armin, Courville Elizabeth

机构信息

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States.

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, United States.

出版信息

Blood Cells Mol Dis. 2017 Mar;63:32-33. doi: 10.1016/j.bcmd.2017.01.003. Epub 2017 Jan 10.

DOI:10.1016/j.bcmd.2017.01.003
PMID:28110131
Abstract
摘要

相似文献

1
Marked discordance between cytogenetic/molecular and morphologic findings in a patient with chronic myeloid leukemia.一名慢性髓性白血病患者的细胞遗传学/分子学与形态学检查结果之间存在明显不一致。
Blood Cells Mol Dis. 2017 Mar;63:32-33. doi: 10.1016/j.bcmd.2017.01.003. Epub 2017 Jan 10.
2
Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.甲磺酸伊马替尼（格列卫）治疗后的慢性髓性白血病。骨髓组织病理学及其与基因状态的相关性。
Am J Clin Pathol. 2003 Jun;119(6):833-41. doi: 10.1309/A4RG-P4LF-12GG-H8MW.
3
Two siblings with chronic myelogenous leukemia.两名患有慢性粒细胞白血病的兄弟姐妹。
J Exp Clin Cancer Res. 2000 Dec;19(4):541-3.
4
[Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].[慢性髓性白血病患者微小残留病的监测：实时聚合酶链反应的临床价值]
Ter Arkh. 2007;79(4):49-53.
5
e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?慢性髓性白血病中的e6a2 BCR-ABL转录本：它与侵袭性疾病有关吗？
Haematologica. 2004 May;89(5):611-3.
6
Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.一名慢性髓性白血病进展为淋巴细胞母细胞危象的患者中导致对甲磺酸伊马替尼和达沙替尼均耐药的序贯突变
Leuk Res. 2008 Apr;32(4):673-4. doi: 10.1016/j.leukres.2007.08.008. Epub 2007 Sep 24.
7
Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL.在通过实时定量聚合酶链反应（RQ-PCR）监测BCR-ABL的伊马替尼治疗的慢性期慢性粒细胞白血病（CML）患者中，常规骨髓细胞遗传学分析的临床价值有限。
Leukemia. 2006 Apr;20(4):664-70. doi: 10.1038/sj.leu.2404139.
8
Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.慢性粒细胞白血病中BCR-ABL的定量实时逆转录聚合酶链反应监测显示血液和骨髓样本结果不一致。
Int J Oncol. 2006 May;28(5):1099-103.
9
Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.伴有罕见变异型b2a3（e13a3）BCR-ABL1融合的慢性髓性白血病
Ann Lab Med. 2016 May;36(3):287-9. doi: 10.3343/alm.2016.36.3.287.
10
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.隐匿性BCR-ABL融合基因作为慢性髓性白血病的变异重排：分子细胞遗传学特征及其对酪氨酸激酶抑制剂治疗的影响
Oncotarget. 2017 May 2;8(18):29906-29913. doi: 10.18632/oncotarget.15369.